NCT07716813

Brief Summary

Pain, defined by the International Association for the Study of Pain as a subjective, sensory, and emotional experience, differs from nociception, which is merely a neural activity. Premature newborns, whose inhibitory fibers are not yet mature due to anatomical and physiological development and who have insufficient endogenous opioid release, experience painful stimuli much more intensely. The inability of this age group to verbally express pain makes the diagnosis, assessment, and management of pain entirely dependent on healthcare professionals. Pain that is not effectively managed leads to stress and loss of comfort in the short term, while in the long term it can cause permanent neurodevelopmental problems and alter the individual's pain threshold later in life. Premature infants, especially those in Neonatal Intensive Care Units (NICUs), are exposed to invasive procedures that cause moderate to severe pain, such as heel prick tests, much more frequently than healthy term infants. In this context, pain management is a fundamental and essential nursing responsibility for the infant's neuroprotective developmental care. The literature shows that various non-pharmacological methods, such as oral sucrose, non-nutritive sucking (NNS), facilitated flexion, and wrapping, are used to alleviate pain during interventional procedures. Although more readily available in NICUs, studies on the effectiveness of oral glucose solutions are more limited compared to sucrose. This research, designed to address this gap in the existing literature, aims to investigate the effect of "oral breast milk, 20%, and 10% dextrose solution administered with supportive positioning methods" on pain reduction during heel prick blood sampling in premature newborns. The results of this research are expected to contribute to the development of a new, easily applicable, effective, and evidence-based nursing intervention strategy for NICUs.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Jul 2026Sep 2026

First Submitted

Initial submission to the registry

July 16, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 18, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 21, 2026

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

July 24, 2026

Status Verified

July 1, 2026

Enrollment Period

28 days

First QC Date

July 16, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

premature babypainbreast milknursing caredextrose

Outcome Measures

Primary Outcomes (1)

  • Change in the mean score of neonatal pain, agitation and sedation scale

    The Neonatal Pain, Agitation, and Sedation Scale has a maximum score of 10, a minimum score of 0, and no lower limit. It is generally interpreted that "the higher the score on the scale, the more pain the baby is in."

    During the procedure

Secondary Outcomes (2)

  • The effect of orally administered breast milk, 10% and 20% dextrose solutions, along with supportive positioning techniques during heel prick blood sampling in premature infants, on heart rate.

    During the procedure

  • The effect of supportive positioning techniques during heel prick blood sampling in premature infants, along with orally administered breast milk, 10% and 20% dextrose solutions, on respiratory rate.

    During the procedure

Study Arms (3)

breast milk group

EXPERIMENTAL

supportive positioning techniques during routine heel prick blood sampling and oral breastfeeding.

Behavioral: Administering oral breast milk in a supportive position

10% dextrose solution group

EXPERIMENTAL

Application of 10% dextrose solution with supportive positioning during routine heel prick blood sampling.

Behavioral: Administering oral 10% dextrose in a supportive position

20% dextrose solution group

EXPERIMENTAL

Application of 20% dextrose solution with supportive positioning during routine heel prick blood sampling.

Behavioral: Administering oral 20% dextrose in a supportive position

Interventions

Application of 20% dextrose solution with supportive positioning during routine heel prick blood sampling.

20% dextrose solution group

Administering oral breast milk in a supportive position

breast milk group

Application of 10% dextrose solution with supportive positioning during routine heel prick blood sampling.

10% dextrose solution group

Eligibility Criteria

Age32 Weeks - 37 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Parental consent for the baby's participation in the study
  • Admission to Mersin University Hospital NICU between July 16, 2026 and December 30, 2026,
  • Gestational age at birth between 33 weeks and 37 weeks,
  • Postnatal age less than 7 days,
  • Heel prick blood test planned within the scope of NTP,
  • Stable clinical condition,
  • Absence of genetic or metabolic problems,
  • Developed sucking-swallowing and breathing coordination,
  • Having been fed at least 30 minutes before the procedure,
  • No experience with invasive procedures in the last 6 hours before the procedure,
  • No administration of non-opioid analgesics in the last 4 hours before the procedure,
  • No administration of opioid analgesics and sedative agents in the last 24 hours before the procedure,
  • Spontaneous respiration at 21% FiO2,
  • Absence of neurological problems (e.g., asphyxia, hypoxic ischemic encephalopathy, intraventricular hemorrhage, periventricular leukomalacia, spinal cord injury…),
  • Absence of contraindications to oral glucose/breast milk administration (e.g., necrotizing enterocolitis or suspicion thereof, feeding intolerance, tracheoesophageal fistula, absence of esophageal atresia…),
  • +1 more criteria

You may not qualify if:

  • Parental disapproval of infant's participation in the study
  • No hospitalization at Mersin University Hospital NICUs between July 16, 2026 and December 30, 2026,
  • Gestational age at birth less than 33 weeks or greater than 37 weeks,
  • Postnatal age greater than 7 days,
  • Heel prick blood test not planned within the scope of NTP,
  • Clinical condition not stable,
  • Lack of developed sucking-swallowing and breathing coordination,
  • Having been fed within 30 minutes of the procedure,
  • Having had invasive procedures experience in the last 6 hours before the procedure,
  • Having received non-opioid analgesics in the last 4 hours before the procedure,
  • Having received opioid analgesics and sedative agents in the last 24 hours before the procedure,
  • Genetic or metabolic problem The following are contraindications:
  • Being on invasive or non-invasive mechanical ventilation support,
  • Having a neurological problem,
  • Oral glucose/breast milk administration being contraindicated,
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University

Mersin, 33343, Turkey (Türkiye)

Location

Related Publications (9)

  • Shann F. Suckling and sugar reduce pain in babies. Lancet. 2007 Mar 3;369(9563):721-723. doi: 10.1016/S0140-6736(07)60335-3. No abstract available.

  • Kim SS. Prevention and management of pain in the neonatal intensive care unit. Clin Exp Pediatr. 2020 Jan;63(1):16-17. doi: 10.3345/kjp.2019.01200. Epub 2020 Jan 15. No abstract available.

  • Jones L, Fabrizi L, Laudiano-Dray M, Whitehead K, Meek J, Verriotis M, Fitzgerald M. Nociceptive Cortical Activity Is Dissociated from Nociceptive Behavior in Newborn Human Infants under Stress. Curr Biol. 2017 Dec 18;27(24):3846-3851.e3. doi: 10.1016/j.cub.2017.10.063. Epub 2017 Nov 30.

  • Maitra S, Baidya DK, Khanna P, Ray BR, Panda SS, Bajpai M. Acute perioperative pain in neonates: An evidence-based review of neurophysiology and management. Acta Anaesthesiol Taiwan. 2014 Mar;52(1):30-7. doi: 10.1016/j.aat.2014.02.004. Epub 2014 Apr 2.

  • Field T. Preterm newborn pain research review. Infant Behav Dev. 2017 Nov;49:141-150. doi: 10.1016/j.infbeh.2017.09.002. Epub 2017 Sep 9.

  • Orovec A, Disher T, Caddell K, Campbell-Yeo M. Assessment and Management of Procedural Pain During the Entire Neonatal Intensive Care Unit Hospitalization. Pain Manag Nurs. 2019 Oct;20(5):503-511. doi: 10.1016/j.pmn.2018.11.061. Epub 2019 May 15.

  • Guo W, Liu X, Zhou X, Wu T, Sun J. Efficacy and safety of combined nonpharmacological interventions for repeated procedural pain in preterm neonates: A systematic review of randomized controlled trials. Int J Nurs Stud. 2020 Feb;102:103471. doi: 10.1016/j.ijnurstu.2019.103471. Epub 2019 Nov 7.

  • McNair C, Campbell-Yeo M, Johnston C, Taddio A. Nonpharmacologic Management of Pain During Common Needle Puncture Procedures in Infants: Current Research Evidence and Practical Considerations: An Update. Clin Perinatol. 2019 Dec;46(4):709-730. doi: 10.1016/j.clp.2019.08.006. Epub 2019 Aug 26.

  • Bucsea O, Pillai Riddell R. Non-pharmacological pain management in the neonatal intensive care unit: Managing neonatal pain without drugs. Semin Fetal Neonatal Med. 2019 Aug;24(4):101017. doi: 10.1016/j.siny.2019.05.009. Epub 2019 Jun 5.

MeSH Terms

Conditions

AgnosiaPremature BirthPain

Interventions

TherapeuticsGlucose

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomization and Masking: Block randomization will be preferred. Twelve different combinations \[ABCBAC (1), ACBBAC (2), AACCBB (3)\] were generated, each with a block size of 6 and containing codes A, B, and C. The combinations were numbered from 1 to 12. Combination numbers (1-12), each consisting of 16 digits in a mixed order, were generated in a random order using a computer program (randomizer.org). To conceal this assignment, each premature neonate will be numbered (1-96) according to the order of admission and placed in sealed, opaque envelopes. These envelopes will be delivered to the NICU head nurse. Supportive positioning practice is the same in the intervention groups, the only difference being oral breast milk, 20% and 10% dextrose solution. Due to the nature of the study, the practitioner and evaluator researchers cannot be masked; however, the identity of the researcher responsible for data entry, analysis, and reporting will be concealed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Nursing, Principal Investigator

Study Record Dates

First Submitted

July 16, 2026

First Posted

July 21, 2026

Study Start

July 18, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

July 24, 2026

Record last verified: 2026-07

Locations